175 related articles for article (PubMed ID: 32847586)
1. Synergistic inhibition of metastatic breast cancer by dual-chemotherapy with excipient-free rhein/DOX nanodispersions.
Wang R; Yang Y; Yang M; Yuan D; Huang J; Chen R; Wang H; Hu L; Di L; Li J
J Nanobiotechnology; 2020 Aug; 18(1):116. PubMed ID: 32847586
[TBL] [Abstract][Full Text] [Related]
2. Nanodrug Formed by Coassembly of Dual Anticancer Drugs to Inhibit Cancer Cell Drug Resistance.
Zhao Y; Chen F; Pan Y; Li Z; Xue X; Okeke CI; Wang Y; Li C; Peng L; Wang PC; Ma X; Liang XJ
ACS Appl Mater Interfaces; 2015 Sep; 7(34):19295-305. PubMed ID: 26270258
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin and rhein loaded nanomicelles attenuates multidrug resistance in human ovarian cancer.
Han NN; Li X; Tao L; Zhou Q
Biochem Biophys Res Commun; 2018 Mar; 498(1):178-185. PubMed ID: 29317204
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antitumor efficacy of arginine modified amphiphilic nanoparticles co-delivering doxorubicin and iSur-pDNA via the multiple synergistic effect.
Song Y; Tang C; Yin C
Biomaterials; 2018 Jan; 150():1-13. PubMed ID: 29028548
[TBL] [Abstract][Full Text] [Related]
5. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
[TBL] [Abstract][Full Text] [Related]
6. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antitumor effects of rhein and doxorubicin in hepatocellular carcinoma cells.
Wu L; Liu X; Cao KX; Ni ZH; Li WD; Chen ZP
J Cell Biochem; 2020 Oct; 121(10):4009-4021. PubMed ID: 30378155
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticles.
Cabeza L; Ortiz R; Arias JL; Prados J; Ruiz Martínez MA; Entrena JM; Luque R; Melguizo C
Int J Nanomedicine; 2015; 10():1291-306. PubMed ID: 25709449
[TBL] [Abstract][Full Text] [Related]
9. A pH-Sensitive Prodrug Nanocarrier Based on Diosgenin for Doxorubicin Delivery to Efficiently Inhibit Tumor Metastasis.
Wei Z; Wang H; Xin G; Zeng Z; Li S; Ming Y; Zhang X; Xing Z; Li L; Li Y; Zhang B; Zhang J; Niu H; Huang W
Int J Nanomedicine; 2020; 15():6545-6560. PubMed ID: 32943867
[TBL] [Abstract][Full Text] [Related]
10. Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
Zhang T; Prasad P; Cai P; He C; Shan D; Rauth AM; Wu XY
Acta Pharmacol Sin; 2017 Jun; 38(6):835-847. PubMed ID: 28216624
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
12. PEGylated nano-graphene oxide as a nanocarrier for delivering mixed anticancer drugs to improve anticancer activity.
Pei X; Zhu Z; Gan Z; Chen J; Zhang X; Cheng X; Wan Q; Wang J
Sci Rep; 2020 Feb; 10(1):2717. PubMed ID: 32066812
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic Identification of Anticancer Metabolites of Australian Propolis and Proteomic Elucidation of Its Synergistic Mechanisms with Doxorubicin in the MCF7 Cells.
Alsherbiny MA; Bhuyan DJ; Radwan I; Chang D; Li CG
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360606
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
[TBL] [Abstract][Full Text] [Related]
15. A pH-sensitive nanotherapeutic system based on a marine sulfated polysaccharide for the treatment of metastatic breast cancer through combining chemotherapy and COX-2 inhibition.
Zhang T; Liu H; Li Y; Li C; Wan G; Chen B; Li C; Wang Y
Acta Biomater; 2019 Nov; 99():412-425. PubMed ID: 31494294
[TBL] [Abstract][Full Text] [Related]
16. Water-Responsive Hybrid Nanoparticles Codelivering ICG and DOX Effectively Treat Breast Cancer via Hyperthermia-aided DOX Functionality and Drug Penetration.
Liu X; Wang C; Ma H; Yu F; Hu F; Yuan H
Adv Healthc Mater; 2019 Apr; 8(8):e1801486. PubMed ID: 30856296
[TBL] [Abstract][Full Text] [Related]
17. Tumor Microenvironment-Triggered Charge Reversal Polymetformin-Based Nanosystem Co-Delivered Doxorubicin and IL-12 Cytokine Gene for Chemo-Gene Combination Therapy on Metastatic Breast Cancer.
Sun Y; Liu L; Zhou L; Yu S; Lan Y; Liang Q; Liu J; Cao A; Liu Y
ACS Appl Mater Interfaces; 2020 Oct; 12(41):45873-45890. PubMed ID: 32924511
[TBL] [Abstract][Full Text] [Related]
18. Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly(L-lactide) grafted polyethylenimine cationic nanoparticles.
Guo O; Li X; Yang Y; Wei J; Zhao Q; Luo F; Qian Z
J Biomed Nanotechnol; 2014 Feb; 10(2):227-37. PubMed ID: 24738331
[TBL] [Abstract][Full Text] [Related]
19. Improved chemotherapy against breast cancer through immunotherapeutic activity of fucoidan decorated electrostatically assembled nanoparticles bearing doxorubicin.
Pawar VK; Singh Y; Sharma K; Shrivastav A; Sharma A; Singh A; Meher JG; Singh P; Raval K; Kumar A; Bora HK; Datta D; Lal J; Chourasia MK
Int J Biol Macromol; 2019 Feb; 122():1100-1114. PubMed ID: 30219515
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
